Heart Failure Telemedicine Programs Prove Effective Six Months After Discharge, Study Finds

Home telemedicine programs for heart failure are effective at preventing death for at least six months after hospitalization, but generally lose any benefit after one year, according to a meta-analysis of clinical trials published today and announced tomorrow at a briefing. These findings, published in the December issue of Health Affairs by a study team led by Feinstein Institute for Medical Research Professor Renee Pekmezaris, Ph.D., help educate health care professionals how to refine heart failure telemedicine programs and about who most benefits from these programs.

Dr. Pekmezaris will speak about this topic at 11:40 a.m., December 4, at the Health Affairs briefing hosted at The National Press Club in Washington, DC.